Baclofen and antidepressant-induced antinociception in formalin test: Possible GABA(B) mechanism involvement

Psychopharmacology

Volumn 142, Issue 4, 1999, Pages 426-431

  Sabetkasai, M ^a   Khansefid, N ^a   Yahyavi, S H ^a   Zarrindast, M R ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Baclofen; Citalopram; Desipramine; Formalin test; Imipramine; Mice

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; CITALOPRAM; DESIPRAMINE; FORMALDEHYDE; IMIPRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANTIDEPRESSIVE AGENTS; BACLOFEN; GABA AGONISTS; MALE; MICE; ORGANOPHOSPHORUS COMPOUNDS; RECEPTORS, GABA-B;

EID: 0032895566     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050909     Document Type: Article

References (41)

1. Abbot FV, Franklin BJ, Ludwik RJ, Melzach R (1994) Apparent lack of tolerance in the formalin test suggests different mechanisms for morphine analgesia in different types of pain. Pharmacol Biochem Behav 15:637-640
2. 3 receptor-mediated antinociception: possible release of GABA. J Neurosci 11:1881-1888
3. Aran S, Hammond DL (1991) Antagonism of baclofen-induced antinociception by intrathecal administration of phaclofen or 2-hydroxy-saclofen, but not δ-aminovaleric acid in the rat. J Pharmacol Exp Ther 257:360-368
4. Baldessarini RJ (1990) Drugs and the treatment of psychiatric disorders. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Pergamon Press, New York, pp 383-435
5. Berettini WH, Nurnberger JI, Hare TA, Simmons-Alling S, Gershon S, Post RM (1983) Reduced plasma and CSF GABA in affective illness: effect of lithium carbonate. Biol Psychiatry 18:185-194
6. B receptors in mammalian function. Wiley, London, pp 47-60
7. B receptor pharmacology. Annu Rev Pharmacol Toxicol 33:109-147
8. Bowery NG, Hill DR, Hudson AL, Doble A, Middlemiss DN, Shaw J, Turnbull M (1980) (-) Baclofen decreases neurotransmitter release in the mammalian CNS by action at a novel GABA receptors. Nature 283:92-94
9. B receptor binding sites on rat whole brain synaptic membrane. Br J Pharmacol 78:191-206
10. Clavelou P, Radhouane D, Thierry O, Alain W, Patrich R (1995) The orofacial formalin test in rat; effect of different formalin concentrations. Pain 62:295-301
11. Coderre TJ, Melzack R (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12:3665-3670
12. Delpon E, Valenzuela C, Perez O, Tamargo J (1993) Electrophysiological effects of the combination of imipramine and desipramine in guinea-pig papillary muscles. J Cardiovasc Pharmacol 21:13-20
13. Dubuisson D, Dennis SG (1977) The formalin test: a quantitative study of the analgesic effects of morphine, neperidine, and brain stem stimulation in rats and cats. Pain 4:161-174
14. Feinmann C (1985) Pain relief by antidepressants: possible modes of action. Pain 23:1-8
15. Feinmann C, Harris M, Cawley R (1984) Psychogenic pain; presentation and treatment. BMJ 228: 436-438
16. Fromm GH, Terrence CP, Chattha AS (1984) Baclofen in the treatment of trigeminal neuralgia: double blind study and long-term follow up. Ann Neurol 15:240-244
17. Gerner RH, Hare TA (1981) CSF GABA levels in normal subjects and patients with depression, schizophrenia, mania and anorexia. Am J Psychiatry 138:1098-1101
18. Gram LF (1983) Antidepressants: receptors pharmacokinetics, and clinical effects. In: Burrows GD, Norman T, Davies B (eds) Antidepressants. Elsevier, Amsterdam, pp 81-95
19. B-receptor mediated inhibition of potassium evoked release of endogenous 5-hydroxytryptamine from mouse frontal cortex. Br J Pharmacol 91:517-522
20. Hunskaar S, Hole K (1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30:103-114
21. Hunskaar S, Fasmer OB, Hole K (1985) Formalin test in mice, a useful technic for evaluating mild analgesic. J Neurosci Meth 14:69-76
22. B receptors in rat brain slices. Neuropharmacology 35:703-712
23. Kvinesdal B, Molin D, Froland A, Gram LF (1984) Imipramine treatment of painful diabetic neuropathy. JAMA 251: 1727-1730
24. Magni G (1991) The use of antidepressants in the treatment of chronic pain. A review of current evidence. Drugs 42:730-748
25. Max MB, Schafer SC, Culnance M, Dubner R, Gracely RH (1988) Association of pain relief with drug side effects in postherptic neuralgia: a single-dose study of clonidine, codeine, ibuprofen and placebo. Clin Pharmacol Ther 43:363-371
26. Max MB, Lynch SA, Muir J, Shoaf SE, Dubner R, Smoller B (1992) Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256
27. B receptors. Eur J Pharmacol 187:27-38
28. Pinto de S, Polikar M, Debono G (1972) Results of international clinical trials with Lioresal. Postgrad Med J [Suppl 5] 48:18-23
29. Potashner SJ (1979) Baclofen: effects on amino acid release and metabolism in slices of guinea-pig cerebral cortex. J Neurochem 32:103-109
30. Reimann W, Zumstein A, Starke K (1982) γ-Aminobutyric acid can both inhibit and facilitate dopamine release in the caudate nucleus of the rabbit. J Neurochem 39:961-969
31. Sabetkasai M, Zarrindast MR (1993) Antinociception: interaction between adenosine and GABA systems. Arch Int Pharmacodyn 322:14-22
32. Sawynok J (1987) GABAergic mechanisms of analgesia: an update. Pharmacol Biochem Behav 26:463-474
33. Sawynok J (1989) The role of ascending and descending noradrenergic and serotonergic pathways in opioid and non-opioid antinociception as revealed by lesion studies. Can J Physiol Pharmacol 67:975-988
34. Shibata M, Ohkubo T, Takahashi H, Inoki R (1989) Modified formalin test: characteristic biphasic pain response. Pain 38:347-352
35. Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes-Jorgensen T, Gram LF (1992) Clinical trials and therapeutics: the selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neurophathy. Clin Pharmacol Ther 52:547-552
36. Tanelian DL, Brose WG (1991) Neuropathic pain can be relieved by drugs that are use-dependant sodium channel blockers: lidocaine, carbamozepine and mexiletine. Anaesthesiology 74:949-951
37. Yaksh TL (1985) Pharmacology of spinal adrenergic system which modulate spinal nociceptive processing. Pharmacol Biochem Behav 22:845-858
38. Young RR, Delwaide PJ (1981) Drug therapy: spasticity. N Engl J Med 304:96-99
39. A antagonists and baclofen analgesia. Gen Pharmacol 19:703-706
40. Zarrindast MR, Moghadampour E (1991) Influences of dopamine agonists and antagonists on baclofen antinociception in mice. Arch Int Pharmacodyn 309:42-50
41. Zarrindast MR, Sabetkasai M (1992) Stress-induced antinociception and GABAergic mechanism. Arch Int Pharmacodyn 318:5-12